The role of granulocyte transfusions in neutropenic patients

M Bishton1, R Chopra

  • 1Department of Haematology, Nottingham City Hospital, UK. raj.chopra@astrazenca.com

Insights

Donor granulocyte infusions need more clinical trials to define their exact role. This review summarizes current studies, logistical challenges, and offers guidance for this therapeutic approach.

Area of Science:

  • Hematology
  • Immunology
  • Transfusion Medicine

Background:

  • Donor granulocyte infusions are used to treat certain infections.
  • Their precise clinical utility and optimal application remain unclear.
  • A lack of well-defined clinical trials hinders understanding.

Purpose of the Study:

  • To review existing studies on donor granulocyte infusions.
  • To identify logistical challenges for future research.
  • To provide a practical guide for clinicians.

Main Methods:

  • Literature review of published studies on granulocyte transfusions.
  • Analysis of logistical and practical considerations for clinical application.
  • Synthesis of findings to inform future research and practice.

Main Results:

  • Limited clinical trials exist, making definitive conclusions difficult.
  • Significant logistical hurdles exist in granulocyte collection and administration.
  • Current evidence suggests potential benefit in specific, severe infections.

Conclusions:

  • Further well-designed clinical trials are essential to establish the efficacy of donor granulocyte infusions.
  • Addressing logistical challenges is crucial for successful implementation and research.
  • A standardized approach and practical guidelines are needed for this therapy.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...